Article
Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
The Journal of infectious diseases - 4 Jan 2018
Woestenberg Petra J, King Audrey J, van Benthem Birgit H B, Donken Robine, Leussink Suzan, van der Klis Fiona R M, de Melker Hester E, van der Sande Marianne A B, Hoebe Christian J P A, Bogaards Johannes A
Abstract excerpt
Background: Observational postmarketing studies are important to assess vaccine effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) vaccine against HPV positivity of vaccine and nonvaccine types in a high-risk population. Methods: We included all vaccine-eligible women from the PASSYON study, a biennial cross-sectional survey in Dutch sexually transmitted infection clinics. Vaginal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.